Advertisement

Picture Berlin Partner Top News Tacalyx Extends Seed Round to €14m 650x100px
Document › Details

CureVac AG. (2/19/19). "Press Release: CureVac to Present at the 8th Annual Leerink Partners Global Healthcare Conference". Tübingen & Boston, MA.

Region Region New York, NY
  Country United States (USA)
Organisations Organisation CureVac AG
  Today CureVac SE
  Group CureVac (Group)
  Organisation 2 SVB Leerink LLC
  Today Leerink Partners (Group)
  Group Leerink Partners (Group)
Products Product SVB Leerink Annual Global Healthcare Conference 2019 New York
  Product 2 mRNA-based drug
Index term Index term CureVac–SVB: investor conference, 201902 supply service CureVac presents at SVB Leerink Global Healthcare Conference in NYC
Person Person Menichella, Daniel L. (Dan) (Kaleido Biosciences 202010– CEO before CureVac + Bamboo Therapeutics + AGTC + Zyngenia)
     


CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive Officer, will present a corporate overview at the 8th Annual Leerink Partners Global Healthcare Conference in New York on Wednesday, February 27, 2019 at 1:50 p.m. ET.

A live broadcast of the presentation will be available at www.curevac.com/en/newsroom/curevacevents. An archived replay of the presentation will be available on the company’s website for approximately 3 months following the presentation.


   
Record changed: 2023-06-05

Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

More documents for CureVac (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px




» top